| 000 | 01720 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516153532.0 | ||
| 264 | 0 | _c20140225 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a2041-4889 | ||
| 024 | 7 |
_a10.1038/cddis.2013.179 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEhrhardt, H | |
| 245 | 0 | 0 |
_aCell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis. _h[electronic resource] |
| 260 |
_bCell death & disease _cJun 2013 |
||
| 300 |
_ae661 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCyclin B _xgenetics |
| 650 | 0 | 4 |
_aCyclin E _xgenetics |
| 650 | 0 | 4 |
_aDexamethasone _xpharmacology |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aG1 Phase Cell Cycle Checkpoints |
| 650 | 0 | 4 | _aG2 Phase Cell Cycle Checkpoints |
| 650 | 0 | 4 | _aGene Knockdown Techniques |
| 650 | 0 | 4 | _aHCT116 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethotrexate _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aTNF-Related Apoptosis-Inducing Ligand _xpharmacology |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aWachter, F | |
| 700 | 1 | _aGrunert, M | |
| 700 | 1 | _aJeremias, I | |
| 773 | 0 |
_tCell death & disease _gvol. 4 _gp. e661 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/cddis.2013.179 _zAvailable from publisher's website |
| 999 |
_c22815470 _d22815470 |
||